DrugLinx - Pharmaceutical News Daily

Pharma

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Article ID

Home
General Pharma

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Pharma

Biotechnology

Conferences/Meetings

Drug Trials

Drug/Product Approvals

Execs on the Move

Financial Reports

M&A/Partnerships

Marketing/Media/ROI

Medical Devices/Products

Physician/Patient Trends

Popular Press

Regulatory Issues

Research & Development

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

MDLinx Email Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 email addresses.
*From Email:
*To Email:
To Email:
To Email:
To Email:
To Email:

AVI BioPharma Joining Russell 3000 Index
AVI BioPharma, Inc. , a developer of RNA-based drugs, announced that immediately following the close of the U.S. markets it will join the broad-market Russell 3000 Index following Russell Investments' annual reconstitution of its comprehensive set of U.S. and global equity indexes. [more...]

AVI BioPharma

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine

Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics

Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor